For Business Development
Walk into every negotiation with the data your counterparty already has.
Solidus benchmarks your deal against 1,600+ verified biopharma transactions — upfronts, milestones, royalties, and deal structures — so you negotiate from evidence, not anecdote.
Deal Terms Calculator
Input your asset's TA, modality, phase, and indication. Get benchmarked upfront, total deal value, milestone, and royalty ranges in seconds — calibrated against SEC 8-K filings.
Comparable Deal Selector
Pull the specific transactions your counterparty will reference. Filter by indication, modality, stage, territory, and deal type. See what similar assets actually transacted for.
Partner Matching
700+ companies scored across 11 strategic dimensions. Know which buyers have the pipeline gaps, financial capacity, and M&A history that make your asset a fit — before the first call.
Buyer-Specific Valuation
The same asset is worth different amounts to different buyers. Solidus calibrates valuations to each acquirer's portfolio gaps, deal history, and strategic premiums.
Monte Carlo Simulation
10,000-iteration probabilistic analysis. See the full distribution of outcomes — not just the median. Know where P10, P50, and P90 land for your specific deal.
Negotiation Playbook
AI-generated playbook with opening position, walk-away, and counterparty-specific talking points. Built from the comp set, not generic advice.
The problem Solidus solves for BD teams
Your counterparty — the pharma company across the table — has a 200-person deal team, a proprietary transaction database, and decades of pattern recognition. Your company has a spreadsheet and whatever your BD lead remembers from the last conference. Solidus closes that gap. Every deal term you propose is backed by verified comparable transactions, not guesswork.